Table 1.

Recipient baseline characteristics

Recipient Characteristic		EVLP N = 18	STANDARD N = 184	Total N = 202
Gender	Male n (%)	13 (72.2)	106 (57.6)	119 (58.9)
	Female n (%)	5 (27.8)	78 (42.4)	83 (41.1)
Age (Years)	n	18	183	201
	Missing	0	1	1
	Median	56	51	52
	IQR	46–59	38–58	38–58
	Range	20–64	18–70	18–70
Diagnosis	COPD n (%)	5 (27.8)	40 (21.7)	45 (22.3)
	Cystic Fibrosis n (%)	4 (22.2)	47 (25.5)	51 (25.2)
	Interstitial Lung Disease n (%)	7 (38.9)	47 (25.5)	54 (26.7)
	Emphysema n (%)	0 (0)	26 (14.1)	26 (12.9)
	Non-CF Bronchiectasis n (%)	1 (5.6)	8 (4.3)	9 (4.5)
	Obliterative Bronchiolitis n (%)	0 (0)	2 (1.1)	2 (1.0)
	Pulmonary Hypertension n (%)	1 (5.6)	3 (1.6)	4 (2.0)
	Other n (%)	0 (0)	9 (4.9)	9 (4.5)
	Missing n (%)	0 (0)	2 (1.1)	2 (1.0)
Diabetes	Yes n (%)	4 (22.2)	33 (18.1)	37 (18.3)
	No n (%)	13 (72.2)	142 (78.0)	155 (76.7)
	Missing n (%)	1 (5.6)	9 (3.9)	10 (5.0)
BMI	n	17	182	199
	Missing	1	2	3
	Median	21.6	23.8	23.7
	IQR	18.4–26.3	20.5–26.5	20.4–26.5
	Range	17.6–32.5	15.4–34.2	15.4–34.2
FEV1 (L)	n	15	176	191
	Missing	3	8	11
	Median	1.2	0.9	0.9
	IQR	0.7–1.9	0.6–1.4	0.6–1.5
	Range	0.5–2.5	0.3–3.6	0.3–3.6
FEV1%	n	15	171	186
	Missing	3	13	16
	Median	29	26	27
	IQR	22–50	20–45	20–45
	Range	15–67	11–105	11–105
Type of Transplant	Single n (%)	2 (11.1)*	24 (13.0)**	26 (13)
	Bilateral n (%)	16 (88.9)	152 (82.6)	168 (83)
	Missing n (%)	0 (0) * 1 left, 1 right	8 (4.4) **9 left, 13 right, 2 NK	8 (4)
Cardiopulmonary Bypass Use	No n (%)	2 (11.1)	46 (25.0)	48 (24)
	Yes n (%)	16 (88.9)	116 (63.0)	132 (65)
	Not known n (%)	0 (0)	22 (12.0)	22 (11)
Source[4]

BMI body mass index, CF cystic fibrosis, COPD chronic obstructive pulmonary disease, EVLP Ex-vivo lung perfusion, FEV forced expiratory volume, IQR inter quartile range, NK not known